Under the deal, Microsoft 365 will be deployed to as many as 1.2 million staff across NHS organisations
Category: Uncategorized
The approval gives patients who relapse a new second-line option for the first time in nearly 20 years
Updated Date: Mon, 08 Jun 2020 00:00:00 EDT
Updated Date: Mon, 08 Jun 2020 00:00:00 EDT
Updated Date: Mon, 08 Jun 2020 00:00:00 EDT
Updated Date: Mon, 08 Jun 2020 00:00:00 EDT
Updated Date: Mon, 08 Jun 2020 00:00:00 EDT
Gilead sees better days ahead for CAR-T therapy Yescarta with Amsterdam manufacturing hub online kblankenship Mon, 06/15/2020 – […]
Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer.